首页 | 本学科首页   官方微博 | 高级检索  
     

莫西沙星治疗脑血管病伴吸入性肺炎的临床观察
引用本文:刘石磊,焦雪,杜娟,陆思静. 莫西沙星治疗脑血管病伴吸入性肺炎的临床观察[J]. 中国药房, 2011, 0(16): 1488-1489
作者姓名:刘石磊  焦雪  杜娟  陆思静
作者单位:[1]辽河油田兴城康复医院,兴城市125100 [2]辽宁医学院附属第一医院,锦州市121001
摘    要:目的:观察莫西沙星治疗脑血管病伴吸入性肺炎患者的有效性和安全性。方法:选择112例脑血管病伴吸入性肺炎患者,应用莫西沙星(0.4g,qd,静脉滴注)治疗,观察其临床疗效、安全性。结果:莫西沙星治疗脑血管病患者吸入性肺炎有效率为86%,痊愈率为55%,细菌清除率为77%,不良反应发生率为7%。结论:莫西沙星治疗脑血管病伴吸入性肺炎效果好,不良反应少。

关 键 词:吸入性肺炎  脑血管病  莫西沙星

Clinical Observation of Moxifloxacin in the Treatment of Cerebrovascular Disease Complicating with Aspiration Pneumonia
LIU Shi-leiLiaohe Oilfield Xingcheng Rehabilitation Hospital,Xingcheng,China JIAO Xue,DU Juan,LU Si-jing. Clinical Observation of Moxifloxacin in the Treatment of Cerebrovascular Disease Complicating with Aspiration Pneumonia[J]. China Pharmacy, 2011, 0(16): 1488-1489
Authors:LIU Shi-leiLiaohe Oilfield Xingcheng Rehabilitation Hospital  Xingcheng  China JIAO Xue  DU Juan  LU Si-jing
Affiliation:(The First Affiliated Hospital of Liaoning Medical University,Jinzhou 121001,China)
Abstract:OBJECTIVE:To evaluate the efficacy and safety of moxifloxacin in the treatment of cerebrovascular disease complicating with aspiration pneumonia.METHODS:112 patients with cerebrovascular disease complicating with aspiration pneumonia who were treated with moxifloxacin(0.4 g,qd,iv.gtt) were enrolled in this study.The clinical efficacy and safety were analyzed.RESULTS:The effective rate and curative rate of moxifloxacin therapy were 86% and 55%,respectively.The bacterial eradication rate was 77%,and the rate of adverse drug reaction was 7%.CONCLUSION:Moxifloxacin therapy is effective in the treatment of cerebrovascular disease complicating with aspiration pneumonia with few adverse drug reaction.
Keywords:Aspiration pneumonia  Cerebrovascular disease  Moxifloxacin
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号